Medpace Holdings, Inc. MEDP
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.50% | 17.24% | 26.50% | 32.03% | 23.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.50% | 17.24% | 26.50% | 32.03% | 23.74% |
| Cost of Revenue | 9.94% | 9.00% | 11.51% | 8.73% | 8.62% |
| Gross Profit | 7.94% | 20.91% | 33.51% | 42.60% | 30.90% |
| SG&A Expenses | 7.66% | 3.08% | -17.24% | -1.14% | -2.31% |
| Depreciation & Amortization | -6.65% | -4.33% | -0.35% | -5.00% | -6.24% |
| Other Operating Expenses | 3.84% | 27.65% | 54.15% | 68.27% | 43.50% |
| Total Operating Expenses | 6.25% | 17.51% | 26.98% | 35.01% | 23.05% |
| Operating Income | 16.74% | 16.22% | 24.65% | 22.25% | 26.31% |
| Income Before Tax | 19.65% | 21.78% | 24.90% | 17.14% | 20.26% |
| Income Tax Expenses | 5.50% | -11.60% | 563.52% | 28.68% | 41.84% |
| Earnings from Continuing Operations | 23.69% | 34.46% | 8.09% | 15.48% | 15.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.69% | 34.46% | 8.09% | 15.48% | 15.25% |
| EBIT | 16.74% | 16.22% | 24.65% | 22.25% | 26.31% |
| EBITDA | 15.63% | 15.14% | 23.21% | 20.71% | 24.26% |
| EPS Basic | 24.56% | 36.50% | 15.47% | 26.41% | 27.18% |
| Normalized Basic EPS | 20.49% | 23.62% | 33.43% | 28.13% | 32.70% |
| EPS Diluted | 25.39% | 37.10% | 16.62% | 26.94% | 28.24% |
| Normalized Diluted EPS | 21.53% | 24.30% | 34.53% | 28.91% | 33.91% |
| Average Basic Shares Outstanding | -0.70% | -1.49% | -6.39% | -8.58% | -9.38% |
| Average Diluted Shares Outstanding | -1.54% | -2.02% | -7.16% | -9.13% | -10.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |